WallStreetZenWallStreetZen

NASDAQ: HSDT
Helius Medical Technologies Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

HSDT past revenue growth

How has HSDT's revenue growth performed historically?
Company
-18.17%
Industry
9.4%
Market
17.57%
HSDT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HSDT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HSDT's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

HSDT earnings and revenue history

Current Revenue
$644.0k
Current Earnings
-$8.9M
Current Profit Margin
-1,374.2%

HSDT Return on Equity

Current Company
-221.1%
Current Industry
10.5%
Current Market
188%
HSDT's Return on Equity (-221.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when HSDT announces earnings.

HSDT Return on Assets

Current Company
-86.2%
Current Industry
5.3%
HSDT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

HSDT Return on Capital Employed

Current Company
-156.67%
Current Industry
8.3%
HSDT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HSDT vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
HSDT$644.00k-$8.89M-$8.85M+6.14%N/A
BIOL$49.16M-$15.44M-$37.62M+1.27%N/A
AFIB$7.16M-$75.07M-$81.66M+27.03%N/A
VERO$76.35M-$26.31M-$37.25M-5.74%N/A
INVO$3.02M-$6.88M-$8.03M+43.62%N/A
View Top Medical Device Stocks

HSDT earnings dates

Next earnings date
May 9, 2024

Helius Medical Technologies Earnings & Revenue FAQ

What were HSDT's earnings last quarter?

On Invalid Date, Helius Medical Technologies (NASDAQ: HSDT) reported Q4 2023 earnings per share (EPS) of -$0.96, up 158.54% year over year. Total Helius Medical Technologies earnings for the quarter were -$1.05 million. In the same quarter last year, Helius Medical Technologies's earnings per share (EPS) was $1.64.

If you're new to stock investing, here's how to buy Helius Medical Technologies stock.

What was HSDT's earnings growth in the past year?

As of Q2 2024, Helius Medical Technologies's earnings has grown year over year. Helius Medical Technologies's earnings in the past year totalled -$8.85 million.

What is HSDT's earnings date?

Helius Medical Technologies's earnings date is Invalid Date. Add HSDT to your watchlist to be reminded of HSDT's next earnings announcement.

What was HSDT's revenue last quarter?

On Invalid Date, Helius Medical Technologies (NASDAQ: HSDT) reported Q4 2023 revenue of $134.00 thousand up 52.48% year over year. In the same quarter last year, Helius Medical Technologies's revenue was $282.00 thousand.

What was HSDT's revenue growth in the past year?

As of Q2 2024, Helius Medical Technologies's revenue has grown -18.17% year over year. This is 27.57 percentage points lower than the US Medical Devices industry revenue growth rate of 9.4%. Helius Medical Technologies's revenue in the past year totalled $644.00 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.